Company Badge
USPTO Data Jan 1 1976 - Nov 10 2026
13 Patents
#18 in Exton, PA
#855 in Pennsylvania
#23,898 in US
#45,181 in the World
Melior Pharmaceuticals I, Inc.
Forward Citations = 57
6 inventors:
Exton, PA, United States of America
Melior Pharmaceuticals I, Inc.
Calculating rank
CIPO Patents = 2
EPO Patents = 3
Forward Citations = 57
Loading Chart...
Loading Chart...
6 inventors (with patents filed for the assignee):
Andrew G Reaume (13 out of 21 patents)
Michael S Saporito (10 out of 18 patents)
Frank L Greenway (3 out of 15 patents)
4. Weina Cong (3 out of 3 patents)
5. Ann Coulter (3 out of 3 patents)
6. Alexander R Ochman (2 out of 2 patents)
7. Christopher K Lipinski (1 out of 1 patent)
13 patents:
11. 8552184 - Compounds and methods for treating disorders related to glucose metabolism (2013-10-08),
Company Overview
Melior Pharmaceuticals I, Inc. is a biopharmaceutical company based in Exton, Pennsylvania, focused on developing innovative therapies for various medical conditions. The organization specializes in advancing drug candidates through clinical development, particularly in the fields of neurology and psychiatry. By leveraging proprietary technologies and a deep understanding of disease mechanisms, Melior aims to address unmet medical needs and improve patient outcomes through its targeted therapeutic approaches.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Melior Pharmaceuticals I, Inc.. Retrieved from https://idiyas.com/company/melior-pharmaceuticals-i
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]